High Molecular Weight Methacrylate (HMWM) Primer Sample Clauses

High Molecular Weight Methacrylate (HMWM) Primer. Primer for the substrate concrete surface shall be a wax-free, low odor, high molecular weight methacrylate primer, and consist of a resin, initiator, and promoter. The primer shall conform to requirements indicated in Table 2, below, and all components shall be supplied by the System Provider. Initiator for the methacrylate resin shall consist of a metal drier and peroxide. If supplied separately from the resin, the metal drier shall not be mixed with the peroxide directly; a VIOLENT EXOTHERMIC REACTION will occur. The containers and measuring devices shall not be stored in a manner that allows leakage or spilling to contact the containers or materials of the other. Table 2 HIGH MOLECULAR WEIGHT METHACRYLATE RESIN PROPERTIES (Tested yearly) Property Test Method Requirement Viscosity** ASTM D 2196 25 cps maximum (Brookfield RVT with UL adapter, 50 RPM at 77 °F) Volatile Content** ASTM D 2369 30 percent, maximum Specific Gravity** ASTM D 1475 0.90 minimum at 77 °F Flash Point ASTM D 3278 180 °F minimum Vapor Pressure** ASTM D 323 1.0 mm Hg, maximum at 77 °F PCC Saturated Surface-Dry Bond Strength (Adhesive) California Test 551, part 5 700 psi, minimum at 24 hours and 70 ± 1°F (with PPC at 12% resin content by weight of the dry aggregate), primed surface **Test shall be performed before initiator is added
AutoNDA by SimpleDocs
High Molecular Weight Methacrylate (HMWM) Primer. Provide a wax-free, low odor, HMWM primer, consisting of a resin, initiator, and promoter. Provide a primer conforming to Table A. Store components according to the System Provider’s recommendations. Provide initiator for the methacrylate resin consisting of a metal drier and peroxide. Provide resin and initiator pre-mixed from the System Provider. Do not store containers and measuring devices in a manner that allows leakage or spilling to contact the containers or materials of the other. TABLE A HMWM Primer Requirements Property Requirement Test Method Apparent Viscosity*, cps, max 25 ASTM D2196, Test Method A (Brookfield RVT with UL adapter, 50 RPM) Volatile Content*, %, max 30 ASTM D2369 Specific Gravity* at 77F, min 0.90 ASTM D1963-85 (1996) Flash Point, F, min 180 ASTM D3278 Vapor Pressure* at 77F, mm Hg, max 1.0 ASTM D323 PPC Saturated Surface-Dry Bond Strength (Adhesive) at 24h ± 15 min, and 70F ± 1F, psi 615 CalTrans Test 551, Part 5 (with initiated PPC at 12% resin content by weight of the dry aggregate), primed surface *Perform test before initiator is added

Related to High Molecular Weight Methacrylate (HMWM) Primer

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Loop Provisioning Involving Integrated Digital Loop Carriers 2.6.1 Where InterGlobe has requested an Unbundled Loop and BellSouth uses IDLC systems to provide the local service to the End User and BellSouth has a suitable alternate facility available, BellSouth will make such alternative facilities available to InterGlobe. If a suitable alternative facility is not available, then to the extent it is technically feasible, BellSouth will implement one of the following alternative arrangements for InterGlobe (e.g. hairpinning):

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

  • Dienste Und Materialien Von Drittanbietern (a) Die Apple-Software gewährt möglicherweise Zugang zu(m) iTunes Store, App Store, Apple Books, Game Center, iCloud, Karten von Apple und zu anderen Diensten und Websites von Apple und Drittanbietern (gemeinsam und einzeln als „Dienste“ bezeichnet). Solche Dienste sind möglicherweise nicht in xxxxx Sprachen oder in xxxxx Ländern verfügbar. Die Nutzung dieser Dienste erfordert Internetzugriff und die Nutzung bestimmter Dienste erfordert möglicherweise eine Apple-ID, setzt möglicherweise dein Einverständnis mit zusätzlichen Servicebedingungen voraus und unterliegt unter Umständen zusätzlichen Gebühren. Indem du diese Software zusammen mit einer Apple-ID oder einem anderen Apple-Dienst verwendest, erklärst du dein Einverständnis mit den anwendbaren Servicebedingungen für diesen Dienst, z. B. den neuesten Apple Media Services-Bedingungen für das Land, in dem du auf diese Services zugreifst, die du über die Webseite xxxxx://xxx.xxxxx.xxx/legal/ internet-services/itunes/ anzeigen und nachlesen kannst

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act.

  • Drug Test The compulsory production and submission of urine and/or blood, in accordance with departmental procedures, by an employee for chemical analysis to detect prohibited drug usage.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Influenza Vaccination The parties agree that influenza vaccinations may be beneficial for patients and employees. Upon a recommendation pertaining to a facility or a specifically designated area(s) thereof from the Medical Officer of Health or in compliance with applicable provincial legislation, the following rules will apply:

  • COVID-19 Residents acknowledge that in March 2020 the World Health Organization declared a global pandemic of the virus leading to COVID-19. The Governments of Canada, the Province of Ontario, and local Governments responded to the pandemic with legislative amendments, controls, orders, by-laws, requests of the public, and requests and requirements to Humber (collectively, the “Directives”). It is uncertain how long the pandemic, and the related Directives, will continue, and it is unknown whether there may be a resurgence of the virus leading to COVID-19 or any mutation thereof (collectively, “COVID- 19”). Without limiting the generality of the foregoing paragraph, Humber shall not be held legally responsible or be deemed to be in breach of this Agreement for any damages or loss arising out of or caused by:

  • Technical Standards Applicable to a Wind Generating Plant i. Low Voltage Ride-Through (LVRT) Capability A wind generating plant shall be able to remain online during voltage disturbances up to the time periods and associated voltage levels set forth in the standard below. The LVRT standard provides for a transition period standard and a post-transition period standard.

Time is Money Join Law Insider Premium to draft better contracts faster.